Synopsys, Inc. $SNPS Shares Purchased by USS Investment Management Ltd

USS Investment Management Ltd lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 17.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,120 shares of the semiconductor company’s stock after acquiring an additional 6,100 shares during the period. USS Investment Management Ltd’s holdings in Synopsys were worth $17,885,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Elevation Wealth Partners LLC grew its holdings in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 27 shares during the period. North Dakota State Investment Board increased its position in Synopsys by 0.5% during the third quarter. North Dakota State Investment Board now owns 5,706 shares of the semiconductor company’s stock worth $2,482,000 after purchasing an additional 29 shares during the last quarter. Oak Grove Capital LLC raised its stake in Synopsys by 1.1% during the third quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock worth $1,260,000 after purchasing an additional 32 shares during the period. Kintegral Advisory LLC raised its stake in Synopsys by 0.6% during the third quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after purchasing an additional 32 shares during the period. Finally, Centaurus Financial Inc. raised its stake in Synopsys by 2.6% during the first quarter. Centaurus Financial Inc. now owns 1,434 shares of the semiconductor company’s stock worth $569,000 after purchasing an additional 36 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SNPS has been the subject of several research reports. Sanford C. Bernstein assumed coverage on shares of Synopsys in a research note on Friday, September 25th. They set an “outperform” rating for the company. Rosenblatt Securities upped their price objective on Synopsys from $575.00 to $620.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Bank of America increased their target price on Synopsys from $500.00 to $600.00 in a research report on Thursday, October 1st. HSBC cut Synopsys from a “buy” rating to a “reduce” rating in a report on Friday, September 25th. Finally, Rothschild & Co Redburn lowered their price target on Synopsys from $560.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Synopsys presently has a consensus rating of “Moderate Buy” and a consensus target price of $577.71.

Read Our Latest Analysis on Synopsys

More Synopsys News

Investors following SNPS have been watching these news items:

  • Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
  • Positive Sentiment: Synopsys-backed Ansys is supporting an integration between Instem’s toxicology tools and its simulation platform, extending the company’s reach into packaging safety and materials-risk workflows. This could broaden use of its simulation ecosystem, though the financial impact is not specified. Synopsys broadens platform reach
  • Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence

Synopsys Stock Down 8.0%

Shares of NASDAQ SNPS opened at $396.55 on Friday. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The company has a market cap of $76.00 billion, a P/E ratio of 70.06, a P/E/G ratio of 1.40 and a beta of 1.18. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The stock has a fifty day moving average price of $448.46 and a 200 day moving average price of $440.14.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The firm’s revenue was up 42.4% compared to the same quarter last year. During the same period last year, the company posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts anticipate that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.

Synopsys declared that its board has approved a share repurchase program on Monday, October 5th that permits the company to buy back $1 billion in shares. This buyback authorization permits the semiconductor company to buy up to 1.1% of its shares through open market purchases. Share buyback programs are often an indication that the company’s board believes its stock is undervalued.

Insider Buying and Selling

In related news, insider Janet Lee sold 1,144 shares of the firm’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total transaction of $574,882.88. Following the sale, the insider directly owned 16,534 shares in the company, valued at approximately $8,308,665.68. This trade represents a 6.47% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Sassine Ghazi sold 14,604 shares of the firm’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the sale, the chief executive officer owned 76,865 shares in the company, valued at approximately $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 117,163 shares of company stock worth $51,366,457 in the last ninety days. 0.56% of the stock is owned by corporate insiders.

Synopsys Company Profile

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.